AB­VC Bio­Phar­ma to break ground in Chi­na, ad­vances 20% stake in Zhonghui re­al es­tate 

Cal­i­for­nia-head­quar­tered AB­VC Bio­Phar­ma is to ex­pand its ge­o­graph­ic reach through an ac­qui­si­tion agree­ment with Zhonghui Unit­ed, with the biotech mov­ing ahead with a 20% own­er­ship …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER